Camila

   
Google
 
Web NewDrugInformation.com

Camila


Drug - Camila
The trade name of the product as shown on the labeling.

Dosage - TABLET; ORAL-28
The product dosage form and route separated by a semi-colon.

Active Ingredient(s) - Norethindrone
Multiple ingredients are in alphabetical order.

Strength - 0.35MG
The potency of the active ingredient(s), Norethindrone. May repeat for multiple part products.

Applicant - BARR
The firm name holding legal responsibility for Camila. The firm name is condensed to a maximum twenty character unique string.

New Drug Application (NDA) Number - 076177
The FDA assigned number to Camila. Format is nnnnnn.

Product Number - 001
The FDA assigned number to identify Camila. Each strength is a separate product. May repeat for multiple part products. Format is nnn.

Therapeutic Equivalence (TE) Code - AB1
The TE Code indicates the therapeutic equivalence rating of generic to innovator Rx products.

Approval Date - Oct 21, 2002
The date Camila was approved as stated in the FDA approval letter to the applicant. The format is Mmm dd, yyyy. Products approved prior to the January 1, 1982 contain the phrase: "Approved prior to Jan 1, 1982".

Reference Listed Drug (RLD) - No
The pioneer or innovator of Camila. The RLD identifies the product Abbreviated New Drug Applications (ANDA) use as a reference. Format is Yes or No.

Type - RX
The group or category of approved drugs Camila is in. Format is RX, OTC, DISCN.

Applicant Full Name - Barr Laboratories Inc
The full name of the firm holding legal responsibility for the new application of Camila.

Camila